Brainomix 360 e-MRI: Supporting Advanced Imaging Assessments
Magnetic Resonance Imaging (MRI) can be used to inform treatment decisions for acute ischemic stroke patients, particularly when assessing eligibility of late-window patients for thrombolysis and thrombectomy.
Brainomix 360 e-MRI is an FDA-cleared visualization and processing tool which provides both analysis and viewing capabilities for Diffusion Weighted Imaging (DWI) and Dynamic Susceptibility Contrast (DSC) perfusion, allowing for side-by-side viewing of different MR sequences along with results.
A Multi-Vendor Solution for MRI
The tool can process DWI scans to generate an Apparent Diffusion Coefficient (ADC) map. An automated algorithm then processes DWI and ADC images to generate a mask where low ADC values are displayed with a computed volume - indicating areas likely to contain restricted diffusion. ADC, bmax, b0, and the ADC mask are displayed side-by-side for ease of viewing.
e-MRI can also process DSC MR volumes to compute standard perfusion parameters, using a robust, delay-insensitive deconvolution algorithm. Outputs include:
- Mismatch volume and results
- Fully configurable parameter and multi-threshold maps
- AIF/VOF curves & MIP
- rCBF, rCBV, Tmax, TTP, MTT
- Motion correction chart
Collaborating and Innovating with our Partners
Winner
Life Sciences & Health Tech Company of the Year
Winner
HealthTech Company of the Year 2024
Winner
Most Transformative HealthTech Company 2024
Winner
Life Sciences & HealthTech Company of the Year 2023
Winner
Innovative Tech Company
Winner
Best Established MedTech Company 2023